Immunohematology Market Report- Recent developments, Top Key Players, Growth and Forecast to 2023

ReportsnReports added a new report on The Immunohematology Market report delivers the clean elaborated structure of the Report comprising each and every business related information of the market at a global level. The complete range of information related to the Immunohematology Market is obtained through various sources and this obtained the bulk of the information is arranged, processed, and represented by a group of specialists through the application of different methodological techniques and analytical tools such as SWOT analysis to generate a whole set of trade based study regarding the Immunohematology Market.

Download a Free PDF Sample of Immunohematology Market Research Report at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=1584806

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Immunohematology pipeline products.

Scope of Immunohematology Market Report:
Extensive coverage of the Immunohematology under development: The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities,The report reviews the major players involved in the development of Immunohematology and list all their pipeline projects,The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage,The report provides key clinical trial data of ongoing trials specific to pipeline products,Recent developments in the segment / industry.

Reason to buy the Report:-
Formulate significant competitor information, analysis, and insights to improve R&D strategies,Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage,Identify and understand important and diverse types of Immunohematology under development,Develop market-entry and market expansion strategies,Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline,In-depth analysis of the product?s current stage of development, territory and estimated launch date.

Purchase report @ https://www.reportsnreports.com/purchase.aspx?name=1584806

Table of contents for Immunohematology Market:
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Immunohematology Overview 6
3 Products under Development 7
3.1 Immunohematology - Pipeline Products by Stage of Development 7
3.2 Immunohematology - Pipeline Products by Segment 8
3.3 Immunohematology - Pipeline Products by Territory 9
3.4 Immunohematology - Pipeline Products by Regulatory Path 10
3.5 Immunohematology - Pipeline Products by Estimated Approval Date 11
4 Immunohematology - Pipeline Products under Development by Companies 12
4.1 Immunohematology Companies - Pipeline Products by Stage of Development 12
4.2 Immunohematology - Pipeline Products by Stage of Development 13
5 Immunohematology Companies and Product Overview 15
5.1 AbSorber AB Company Overview 15
5.2 Amity University Company Overview 16
5.3 Arizona State University Company Overview 17
5.4 Biofortuna Ltd Company Overview 18
5.5 Grifols SA Company Overview 23
5.6 Haemonetics Corp Company Overview 24
5.7 Immucor, Inc. Company Overview 25
5.8 Ortho-Clinical Diagnostics Inc Company Overview 26
5.9 Quotient Limited Company Overview 28
5.10 TBG Diagnostics Ltd Company Overview 34
5.11 Transfusion & Transplantation Technologies (Inactive) Company Overview 37
6 Immunohematology- Recent Developments 42
6.1 Jun 18, 2018: Quotient Reports Concordance Data from the MosaiQ European Field Trial 42
6.2 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 43
6.3 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics 43
6.4 May 29, 2018: Quotient Names Franz Walt As Chief Executive Officer 44
6.5 May 29, 2018: Quotient Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Updates on CEO Appointment and MosaiQ European Field Trials 45
6.6 May 25, 2018: Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends 47
6.7 May 23, 2018: Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency 48
6.8 May 17, 2018: Quotient Reports Commencement of EU Blood Grouping Field Trial 49
6.9 May 15, 2018: Prenatal testing of the foetal rhesus factor: test is reliable, but benefit is unclear 49
6.10 May 14, 2018: Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents 51
6.11 May 08, 2018: Haemonetics Appoints Said Bolorforosh Executive Vice President, Chief Technology Officer 52
6.12 May 08, 2018: Bio-Rad Announces First Quarter 2018 Financial Results 52
6.13 May 08, 2018: Haemonetics Reports 4th Quarter and Fiscal Year 2018 Results and Provides Fiscal 2019 Guidance 53
6.14 May 08, 2018: Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future 55
6.15 May 03, 2018: Siemens Healthineers fully on track to meet the targets 55
6.16 May 03, 2018: Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales 56
6.17 Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018 60
6.18 Mar 28, 2018: Medix Biochemica Launch NT-proBNP antibody 1309 available 62
6.19 Mar 26, 2018: Quotient Reports Blood Grouping Concordance Data From MosaiQ Verification and Validation Studies and Updates on the Completion of Its Sale Leaseback Transaction 62
6.20 Mar 26, 2018: Quotient Announces Retirement of Paul Cowan, Chairman and Chief Executive Officer; Franz Walt Named as Interim Chief Executive Officer 63
6.21 Feb 27, 2018: Bio-Rad Reports Fourth-Quarter and Full-Year 2017 Financial Results 64
6.22 Feb 20, 2018: Quotient Announces Appointment of Franz Walt as Non-Executive Director 66
6.23 Feb 20, 2018: Quotient Announces the Sale and Leaseback of its Edinburgh, Scotland Manufacturing and R&D Facility 66
6.24 Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017 67
6.25 Feb 06, 2018: Haemonetics 3rd Quarter Fiscal 2018 Earnings 67
6.26 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics 69
6.27 Jan 25, 2018: Ellen M. Zane Rejoins Haemonetics Board of Directors 70
6.28 Jan 16, 2018: Avi Pelossof Appointed President and CEO of Immucor 70
6.29 Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech 71
6.30 Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange 72
6.31 Nov 02, 2017: Grifols increases its revenues by 10% to Euros 3,250 million and grows net profit by 6.3% to reach Euros 432 million 72
6.32 Nov 02, 2017: Bio-Rad Reports Third-Quarter 2017 Financial Results 76
6.33 Oct 30, 2017: Quotient Reports Second Quarter Fiscal 2018 Financial Results 77
6.34 Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017 79
6.35 Oct 24, 2017: SYGNIS announces the launch of the Universal Lateral Flow Assay kit and associated patent filing 79
6.36 Oct 18, 2017: Robert E. Abernathy Joins Haemonetics Board of Directors 80
6.37 Oct 02, 2017: Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology and Demonstrate Its Entire Transfusion Medicine Portfolio at the 2017 AABB Annual Meeting 80
6.38 Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 81
6.39 Sep 12, 2017: Quotient Reports Results From Latest MosaiQ Performance Evaluation Studies involving MosaiQ IH Microarray 83
6.40 Aug 07, 2017: Quotient Reports Results From Ongoing MosaiQ Performance Evaluation Studies and First Quarter Fiscal 2018 Financial Results 84
6.41 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 86
6.42 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by the growth of its main divisions 87
6.43 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 94
And more...

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

Akshay HodavdekarReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.